Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Kangaspeska

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Discovery|May 16, 2012
KRAS oncogene rearrangements and gene fusions: unexpected rare encounters in late-stage prostate cancersHenrik Edgren, Sara Kangaspeska, Olli Kallioniemi
Molecular Oncology|April 23, 2009
E2-mediated cathepsin D (CTSD) activation involves looping of distal enhancer elementsNancy Bretschneider, Sara Kangaspeska, Martin Seifert, et al.
Plos One|November 3, 2012
Reanalysis of RNA-sequencing data reveals several additional fusion genes with multiple isoformsSara Kangaspeska, Susanne Hultsch, Henrik Edgren, et al.
BMC Cancer|August 26, 2018
Association of tamoxifen resistance and lipid reprogramming in breast cancerSusanne Hultsch, Matti Kankainen, Lassi Paavolainen, et al.
BMC Cancer|July 6, 2016
Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancerSara Kangaspeska, Susanne Hultsch, Alok Jaiswal, et al.
Nature|March 7, 2008
Transient cyclical methylation of promoter DNASara Kangaspeska, Brenda Stride, Raphaël Métivier, et al.
Genome Biology|January 21, 2011
Identification of fusion genes in breast cancer by paired-end RNA-sequencingHenrik Edgren, Astrid Murumagi, Sara Kangaspeska, et al.
Cancer Research|February 24, 2011
Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cellsPäivi Östling, Suvi-Katri Leivonen, Anna Aakula, et al.
Science Advances|February 19, 2019
Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cellsGiovanni Nassa, Annamaria Salvati, Roberta Tarallo, et al.
Science Translational Medicine|March 28, 2014
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancerThushangi N Pathiraja, Shweta R Nayak, Yuanxin Xi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Discovery|May 16, 2012
KRAS oncogene rearrangements and gene fusions: unexpected rare encounters in late-stage prostate cancersHenrik Edgren, Sara Kangaspeska, Olli Kallioniemi
Molecular Oncology|April 23, 2009
E2-mediated cathepsin D (CTSD) activation involves looping of distal enhancer elementsNancy Bretschneider, Sara Kangaspeska, Martin Seifert, et al.
Plos One|November 3, 2012
Reanalysis of RNA-sequencing data reveals several additional fusion genes with multiple isoformsSara Kangaspeska, Susanne Hultsch, Henrik Edgren, et al.
BMC Cancer|August 26, 2018
Association of tamoxifen resistance and lipid reprogramming in breast cancerSusanne Hultsch, Matti Kankainen, Lassi Paavolainen, et al.
BMC Cancer|July 6, 2016
Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancerSara Kangaspeska, Susanne Hultsch, Alok Jaiswal, et al.
Nature|March 7, 2008
Transient cyclical methylation of promoter DNASara Kangaspeska, Brenda Stride, Raphaël Métivier, et al.
Genome Biology|January 21, 2011
Identification of fusion genes in breast cancer by paired-end RNA-sequencingHenrik Edgren, Astrid Murumagi, Sara Kangaspeska, et al.
Cancer Research|February 24, 2011
Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cellsPäivi Östling, Suvi-Katri Leivonen, Anna Aakula, et al.
Science Advances|February 19, 2019
Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cellsGiovanni Nassa, Annamaria Salvati, Roberta Tarallo, et al.
Science Translational Medicine|March 28, 2014
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancerThushangi N Pathiraja, Shweta R Nayak, Yuanxin Xi, et al.
Pageof 1